|
|
Post by sportsrancho on Jun 4, 2017 12:03:35 GMT -5
Great thread kc, thank you so much for going and for what you learned and shared with us!
|
|
|
|
Post by peppy on Jun 4, 2017 12:10:40 GMT -5
Having attended the event on Saturday and staying for the entire event. I have a better view of the entire diabetes market place. I learned that I am a Type 3 diabetic. Yes Type 3. That is a person who knows or worries about a person who is a diabetic. First and foremost Dr. Steven Edelman and his TCOYD group is the real deal. Meeting him in person and chatting with him you learn about his passion for helping diabetics. I have validated the effectiveness of the product by attending the TCOYD event yesterday in Kansas City. I saw how it was receive by diabetics. I personally asked Dr. Steven Edelman about Afrezza and he pulled his Techsphere out of his pocket and said he loved Afrezza and his Partner Dr. Jeremy Pettus did too. During his presentation he presented all diabetes medicines since his group represents the entire spectrum. But his eyes gleamed when talking one on one with me about afrezza. You can see Dr. Edelman believes He was glad to pose with Rich Herrera with both of them holding their Technosphere. He again posed at the MannKind booth. In the vendor arena I watched folks coming buy the MannKind booth. They were excited. Seems that many of the Type 2 folks didn't even know about Afrezza. Hopefully Mannagement will focus future resources towards type 2. There was a Chef there with a Both and we were chatting about Afrezza and the MannKind rep showed him the On Drop Chrome testing kit and he said Wow! That was exciting and he wanted to go buy one immediately. His view also was that Afrezza will be a winner because of younger people like new technology that Afrezza and One drop brings to the market. There were 4 MannKind representatives there The local KC Rep, one from Omaha and Anthony (Duck Fiabetes) Hightower, Cynthia Rogers-Celt. We should be proud in the way that all four of them represent MannKind. They are passionate about the work they do. I watched from a distance how the interacted with folks stopping in at the booth and you could watch how attendees were smiling and picking up the sample Inhalers and materials to take home to read. Rick Herrera was there too. He was telling his story to people who wanted to know about using Afrezza. Rick has been using Afrezza for almost two years. He is a type 2. His A1C continues to drop. Last Thursday evening he was invited to be a guess speaker at a KC area JDRF event where many of the attendees were very appreciative and greatful to hear Rick's Afrezza story. If TCOYD is in your city take a chance and invest a day to learn more about the entire diabetes market. It will give you a better understanding of the clutter of products on the market and why Endo and HCP are slow to adapt to a new product like Afrezza. I sat in on a couple of sessions. One was about HCP professionals / patients and how they relate or hear each other. It was a very good session that was conducted by Dr. Edelman and Dr. Polansky. One gets the understanding how difficult it is to make changes in a regiment of treatment whether or not its working. Quote: I personally asked Dr. Steven Edelman about Afrezza and he pulled his Techsphere out of his pocket and said he loved Afrezza and his Partner Dr. Jeremy Pettus did too. During his presentation he presented all diabetes medicines since his group represents the entire spectrum. But his eyes gleamed when talking one on one with me about afrezza.
reply: the way I see it, Edelman should know. Edelman uses Afrezza. Edelman can choose any rapid acting insulin. Why would Edelman choose to use Afrezza to control his type 1 diabetes? aye.... Is it because he has eyeballs?..... he is not blind, he can see? I know this is at nauseam..... I just think it is so stupid, we all have to pretend we can not see.... "Afrezza...keeps your blood glucose from going high in the first place." Who came up with this system that we can not believe our eyes? aye?
|
|
|
|
Post by kc on Jun 4, 2017 12:15:36 GMT -5
Dr. Edelman is a thought leader respected by the entire industry. I agree with you. He likes things that make compliance easier for a resisting diabetic who is in denial of needing treatment. The investment of an entire day was well worth it. While the even was going on they also had a CME training event concurrently for DR and HCP who were there. For that activity. Today MannKind is the step child. Hopefully we would grow up and mature nicely.
|
|
|
|
Post by mountain74 on Jun 4, 2017 16:25:48 GMT -5
How much does attendance at these events cost Mannkind? I recall reading here how MNKD had originally planned to skip the ADA meeting because they didn't think it was worth the expense. Do they ever do any kind of post-marketing surveys or have any method to assay the effect of their participation in such events?
|
|
|
|
Post by kc on Jun 4, 2017 16:49:29 GMT -5
I think you have to attend events like this to get visibility. Is it cost-effective? Nobody really knows. Regarding the 2017 ADA I think they need to be there to show they are a viable organization. I think originally they were thinking about skipping it since most of the attendees are international.
They made a good decision to attend it since their competitors will be there exhibiting their products.
|
|
|
|
Post by barnstormer on Jun 4, 2017 16:57:34 GMT -5
TYCOD is not sponsored by MNKD or at least not the TCOYD events in San Diego. Other insulin companies are sponsors. Edelman is a diabetic and Afrezza user
|
|
|
|
Post by kc on Jun 4, 2017 17:26:51 GMT -5
Correct he works with just about every company who is involved in treating Diabetes. Also does on going CME training for doctors and other healthcare professionals.
|
|
|
|
Post by sayhey24 on Jun 4, 2017 19:39:14 GMT -5
KC - awesome update, much thanks! Edelman is also the architect of the Onduo protocol. Did he or anyone mention Onduo and what they are up to?
|
|
|
|
Post by kc on Jun 5, 2017 10:12:34 GMT -5
KC - awesome update, much thanks! Edelman is also the architect of the Onduo protocol. Did he or anyone mention Onduo and what they are up to? Not specifically mentioning Onduo but his is very engaged about Tech and referred to his CGM multiple times and various other Tech information for staying on top of numbers. |
|
|
|
Post by peppy on Jun 5, 2017 10:23:04 GMT -5
Correct he works with just about every company who is involved in treating Diabetes. Also does on going CME training for doctors and other healthcare professionals. yes. I remember when I would hear people saying something like this.... "Doctor if it was you, or your loved one, what would you do?" Edelman uses Afrezza. So the doctor has shown us, if it was him, "What would he do?"
|
|
|
|
Post by kc on Jun 15, 2017 18:39:28 GMT -5
Dr. Edelman of TCOYD
|
|
|
|
Post by sayhey24 on Jun 15, 2017 19:31:39 GMT -5
KC - thanks for posting. I think this is a really big deal and should have its own thread. It should probably headline the NYT, IMO. Afrezza - Game Changer
Steven Edelman, MD, an Endocrinologist at the University of California, San Diego calls the product a "game changer" because it’s easier to use and delivers the insulin in a way that more closely mimics a normal working pancreas.
|
|
|
|
Post by kc on Jun 15, 2017 21:51:07 GMT -5
|
|
